Equity Capital Markets

Company · CIK 1426332

NGM BIOPHARMACEUTICALS INC

CIK1426332 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2019-05-16

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-272509
ShelfEffective
 2023-06-082024-04-084
333-238991
ShelfEffective
 2020-06-052021-01-065
333-227608
IPOFinal prospectus
 2018-09-282019-04-045

Filings

15
FiledFilingRegistrationAccession
2024-04-08EFFECTDeclared effective 333-2725099999999995-24-000883
2023-08-04EFFECTDeclared effective 333-2725099999999995-23-002283
2023-08-04424B5Shelf takedown 333-2725090001193125-23-203974
2023-06-08S-3Shelf registered 333-2725090001193125-23-162980
2021-01-06424B5Shelf takedown 333-2389910001193125-21-003155
2021-01-04424B5Shelf takedown 333-2389910001193125-21-000952
2020-06-16EFFECTDeclared effective 333-2389919999999995-20-001451
2020-06-16424B5Shelf takedown 333-2389910001193125-20-170479
2020-06-05S-3Shelf registered 333-2389910001193125-20-162327
2019-04-04424B1Final prospectus 333-2276080001193125-19-098020
2019-04-03EFFECTDeclared effective 333-2276089999999995-19-000581
2019-04-01S-1/AAmendment 333-2276080001193125-19-094494
2019-03-25S-1/AAmendment 333-2276080001193125-19-084550
2018-09-28S-1Registration filed 333-2276080001193125-18-287727
2018-08-10DRSDraft made public 377-022130000950123-18-008070

All filings of this company · CSV